Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 3860743, 6 pages
https://doi.org/10.1155/2018/3860743
Research Article

Fecal Microbiota Transplantation Is Effective in Relieving Visceral Hypersensitivity in a Postinfectious Model

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China

Correspondence should be addressed to Jun Song; moc.621@nuj111gnos

Received 3 August 2017; Revised 9 December 2017; Accepted 24 December 2017; Published 30 January 2018

Academic Editor: Toshimi Chiba

Copyright © 2018 Tao Bai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. H. Farzaei, R. Bahramsoltani, M. Abdollahi, and R. Rahimi, “The role of visceral hypersensitivity in irritable bowel syndrome: Pharmacological targets and novel treatments,” Journal of Neurogastroenterology and Motility, vol. 22, no. 4, pp. 558–574, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. E. S. Kim, J. H. Cheon, J. J. Park et al., “Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: Focus on pain perception,” Journal of Gastroenterology and Hepatology, vol. 25, no. 7, pp. 1232–1238, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Sood, G. R. Law, and A. C. Ford, “Diagnosis of IBS: Symptoms, symptom-based criteria, biomarkers or ‘psychomarkers’?” Nature Reviews Gastroenterology & Hepatology, vol. 11, no. 11, pp. 683–691, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. V. D. Felice, R. D. Moloney, J. F. Cryan, T. G. Dinan, and S. M. O'Mahony, “Visceral pain and psychiatric disorders,” Modern Trends in Pharmacopsychiatry, vol. 30, pp. 103–119, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. P. Hungin, P. J. Whorwell, J. Tack, and F. Mearin, “The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects,” Alimentary Pharmacology & Therapeutics, vol. 11, no. 5, pp. 643–650, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. S. M. O'Mahony, T. G. Dinan, and J. F. Cryan, “The gut microbiota as a key regulator of visceral pain,” Pain, vol. 158, pp. S19–S28, 2017. View at Publisher · View at Google Scholar
  7. C. L. Sears, “A dynamic partnership: celebrating our gut flora,” Anaerobe, vol. 11, no. 5, pp. 247–251, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. R. D. Moloney, A. C. Johnson, S. M. O'Mahony, T. G. Dinan, B. G.-V. Meerveld, and J. F. Cryan, “Stress and the microbiota–gut–brain axis in visceral pain: relevance to irritable bowel syndrome,” CNS Neuroscience & Therapeutics, vol. 22, no. 2, pp. 102–117, 2016. View at Publisher · View at Google Scholar
  9. F. Altmann, P. Kosma, A. O'Callaghan et al., “Genome analysis and characterisation of the exopolysaccharide produced by bifidobacterium longum subsp. Longum 35624™,” PLoS ONE, vol. 11, no. 9, Article ID e0162983, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. E. F. Verdú, P. Bercik, M. Verma-Gandhu et al., “Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice,” Gut, vol. 55, no. 2, pp. 182–190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Rousseaux, X. Thuru, and A. Gelot, “Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors,” Nature Medicine, vol. 13, no. 1, pp. 35–37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. P. Hungin, C. Mulligan, B. Pot et al., “Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice—an evidence-based international guide,” Alimentary Pharmacology & Therapeutics, vol. 38, no. 8, pp. 864–886, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Lyte, “Microbial Endocrinology in the Microbiome-Gut-Brain Axis: How Bacterial Production and Utilization of Neurochemicals Influence Behavior,” PLoS Pathogens, vol. 9, no. 11, Article ID e1003726, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Sharon, N. Garg, J. Debelius, R. Knight, P. C. Dorrestein, and S. K. Mazmanian, “Specialized metabolites from the microbiome in health and disease,” Cell Metabolism, vol. 20, no. 5, pp. 719–730, 2014. View at Publisher · View at Google Scholar
  15. R. M. Stilling, M. van de Wouw, G. Clarke, C. Stanton, T. G. Dinan, and J. F. Cryan, “The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?” Neurochemistry International, vol. 99, pp. 110–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. Ott, G. H. Waetzig, A. Rehman et al., “Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection,” Gastroenterology, vol. 152, no. 4, pp. 799–811, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Long, Y. Liu, J. Tong, W. Qian, and X. Hou, “Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome,” European Journal of Pharmacology, vol. 636, no. 1–3, pp. 159–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. G. A. Castro and D. Fairbairn, “Carbohydrates and lipids in Trichinella spiralis larvae and their utilization in vitro.,” Journal of Parasitology, vol. 55, no. 1, pp. 51–58, 1969. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Myers-Morales, K. M. Bussell, and S. E. D'Orazio, “Fecal transplantation does not transfer either susceptibility or resistance to food borne listeriosis in C57BL/6 and BALB/c/By mice,” F1000Res, vol. 2, p. 177, 2013. View at Google Scholar
  20. H. Wang, J. Gong, and W. Wang, “Are there any different effects of bifidobacterium, lactobacillus and streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model?” PLoS ONE, vol. 9, no. 3, Article ID e90153, 2014. View at Publisher · View at Google Scholar
  21. E. L. Overman, J. E. Rivier, and A. J. Moeser, “CRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-α,” PLoS ONE, vol. 7, no. 6, Article ID e39935, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Crouzet, E. Gaultier, C. Del'Homme et al., “The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota,” Neurogastroenterology & Motility, vol. 25, no. 4, pp. e272–e282, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, L. Li, C. Guo et al., “Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: A meta-analysis,” BMC Gastroenterology, vol. 16, no. 1, article no. 62, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Sender, S. Fuchs, and R. Milo, “Revised Estimates for the Number of Human and Bacteria Cells in the Body,” PLoS Biology, vol. 14, no. 8, Article ID e1002533, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Zhang, Y. Xue, H. Wang et al., “Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice,” World Journal of Gastroenterology, no. 27, pp. 9106–9115, 2014. View at Publisher · View at Google Scholar · View at Scopus